Sino Biopharmaceutical (HK:1177) has released an update.
Sino Biopharmaceutical has announced the purchase of 6 million shares, at an average price of HK$4.12 per share, for a total of approximately HK$24.7 million, under its restricted share award scheme. The shares, which represent about 0.032% of the company’s total shares in issue, were acquired from the market by the Trustee on October 7, 2024, to benefit selected participants. The company’s board retains discretion over the number of shares to be awarded and further purchases.
For further insights into HK:1177 stock, check out TipRanks’ Stock Analysis page.
